Jena Biopharma

Jenapharm is a leading German pharmaceutical company headquartered in Jena, specializing in the development and marketing of hormonal products for women's and men's healthcare. Founded in 1950, the company established a legacy in steroid chemistry and became a market leader in oral contraceptives and hormone replacement therapies in Germany. Since its acquisition by the Bayer Group, Jenapharm has operated as a specialized subsidiary focusing on therapeutic areas such as contraception, endometriosis, and the management of menopause. Its product portfolio includes prominent brands like Valette, Visanne, and Qlaira, reinforcing its position as a key player in the European endocrinology and reproductive health market.